United States of America
Elizabeth A. McGraw, currently serves as General Counsel for Elanco Animal Health, a division of Eli Lilly and Company. McGraw leads a global team of legal professionals, with responsibilities for the legal affairs of Elanco around the world. Before assuming her current role, McGraw was the General Patent Counsel for Elanco for over five years, managing the global Intellectual Property portfolio for Elanco Animal Health, where she gained experience in product life-cycle planning, transactional work, and antitrust issues. Prior to joining Elanco, McGraw practiced as an in-house patent counsel for Eli Lilly and Company in Indianapolis for over 14 years, where she gained experience in global patent portfolio and exclusivity creation and managed the international patent litigation associated with gemcitabine. McGraw received her J.D. from the McKinney School of Law at Indiana University in 2002, and earned her B.S. in chemistry from Ball State University in 1993. McGraw is a native of Indiana and resides with her family in Indianapolis.